Common Side Effects of Lurbinectedin
Lurbinectedin (brand name Zepzelca), used for metastatic small cell lung cancer, frequently causes hematologic toxicities like neutropenia (57% of patients, grade 3/4 in 37%), anemia (52%, grade 3/4 in 25%), and thrombocytopenia (37%, grade 3/4 in 13%). Non-hematologic effects include fatigue (42%), nausea (39%), decreased appetite (35%), musculoskeletal pain (33%), dyspnea (27%), constipation (25%), vomiting (23%), diarrhea (21%), and edema (20%).[1][2]
Severe or Serious Side Effects
Grade 3/4 adverse events occur in over 90% of patients, including severe bone marrow suppression leading to febrile neutropenia or infections. Rhabdomyolysis (muscle breakdown) is a risk, with monitoring required. Respiratory issues like pneumonitis and hepatotoxicity (elevated liver enzymes) can be serious. Discontinuation due to toxicity happens in about 10% of cases.[1][2]
What Causes These Side Effects?
Lurbinectedin inhibits RNA polymerase II, disrupting cancer cell transcription but also affecting healthy cells, especially rapidly dividing bone marrow and gut cells. This explains blood count drops and gastrointestinal symptoms. Pre-existing low blood counts or liver issues increase risks.[1][3]
How Long Do Side Effects Last?
Most resolve within weeks after dose delays or reductions, but hematologic effects peak 7-14 days post-infusion and recover by day 21. Fatigue and nausea often persist longer, managed supportively.[1][2]
Management and Precautions
Monitor complete blood counts weekly, liver function, and creatinine clearance before each dose. Use G-CSF for neutropenia prophylaxis after grade 4 events. Dose reduce or hold for grade 3/4 toxicities. Avoid in patients with active infections or severe organ dysfunction. CYP3A inhibitors/inducers affect exposure.[1][2][3]
Patient Experiences and Real-World Data
In trials, 69% needed transfusions or growth factors. Post-approval reports note similar profiles, with some patients experiencing prolonged fatigue impacting quality of life.[2]
Sources
[1]: FDA Zepzelca Label
[2]: Zepzelca Prescribing Information
[3]: Drugs.com Lurbinectedin Side Effects